We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Common Virus Found Associated with Colon Cancer

By Biotechdaily staff writers
Posted on 10 Dec 2002
A study has found an association between a common human virus and colon cancer, suggesting that treatment or vaccines against the virus may prevent colon tumors. More...
The study was published in the December 2002 issue of Cancer Research.

The virus, called JC virus (JCV), infects more than 90% of the worldwide population, usually during childhood, according to the researchers. The virus is most likely to infect humans through the upper respiratory tract, but remains in a latent stage in most people throughout their lives. JCV can become active, however, in people whose immune systems are depressed and may contribute to cancer in the brain or cause progressive multifocal leukoencephalopathy.

The virus may also enter humans orally through contaminated food or water. In fact, the JCV particles survive in raw sewage. "Re-infection of the human population through contaminated water or food can take the virus into different organs, which in this case may be the intestinal tract,” says Kamel Khalili, Ph.D., a co-investigator and professor and director of the Center for Neurovirology and Cancer Biology at Temple University (Philadelphia, PA, USA; www.temple.edu).

Once in the intestinal tract, JVC expresses the viral protein T-antigen, which has oncogenic potential and associates with beta-catenin, a protein that controls cell division and balances many biologic events in cells. The T-antigen deregulates the function of beta-catenin, which induces the growth of tumors. Gene amplification showed the presence of the viral early genome in 22 of 27 tumors sampled, and the expression of the viral proteins T-antigen and Agnoprotein was found in more than 50% of the samples.
The researchers are not certain whether the JC virus actually causes tumors or is a co-factor or whether its presence is simply a coincidence.

"We can start developing strategies and vaccines against JC virus, which will hopefully lead to the prevention of the tumors it may induce,” notes Dr. Khalili.




Related Links:
Temple University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Silver Member
Connectivity Solution
EKF Link
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.